Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px
All >

News > United Kingdom (GB)

Please find below news from the United Kingdom (Great Britain) as well as about organisations from this country.

Total search results: 2510 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Qiagen N.V.. (7/11/18). "Press Release: Qiagen Partners with U.K. to Expand Biomarker Research in Manchester". Manchester & Hilden. 2018-07-11
Wellcome Trust, The. (7/10/18). "Press Release: Director’s Update. Taking Risks on Bold Idease". 2018-07-10
AMS Biotechnology (Europe) Ltd.. (7/6/18). "Press Release: AMSBIO and University of Strathclyde Jointly Launch New Screening Company". 2018-07-06
Coulter Partners. (7/5/18). "Press Release: Coulter Partners Secures Chief Executive Officer for Ovizio". 2018-07-05
Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne. 2018-07-02
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Kymab Ltd.. (6/28/18). "Press Release: Kymab and Roche Clinical Trial Agreement for KY1044". Cambridge. 2018-06-28
NodThera Ltd.. (6/25/18). "Press Release: NodThera Secures £28 Million ($40 Million) Series A Financing". Cambridge. 2018-06-25
Autolus Therapeutics plc. (6/22/18). "Press Release: Autolus Announces Pricing of Initial Public Offering". London. 2018-06-22
Silence Therapeutics plc. (6/21/18). "Press Release: Silence Therapeutics Strengthens Board and Leadership Team". 2018-06-21
AdoRx Therapeutics Ltd.. (6/21/18). "Press Release: AdoRx Therapeutics Announces Initial funding of $10 Million for the Discovery of New Cancer Therapeutics". Edinburgh. 2018-06-21
PhoreMost Ltd.. (6/21/18). "Press Release: PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs". Cambridge. 2018-06-21
Labstep Ltd.. (6/20/18). "Press Release: Seedcamp Backed ScienceTech Startup Labstep Raises £1 Million to Launch Marketplace and Double Its Team". London. 2018-06-20
Intrexon Corporation. (6/19/18). "Press Release: Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes". Oxford. 2018-06-19
Freeline Therapeutics Ltd.. (6/19/18). "Press Release: Freeline Secures Over £88 Million of Funding". London. 2018-06-19
Crescendo Biologics Ltd.. (6/18/18). "Press Release: Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director". Cambridge. 2018-06-18
GlaxoSmithKline plc. (6/14/18). "Press Release: ViiV Healthcare Reports Landmark Phase III Studies for Dolutegravir and Lamivudine, Demonstrating the Ability to Control HIV with a Two-Drug Regimen in Treatment Naïve Patients". London. 2018-06-14
British Business Bank. (6/13/18). "Press Release: £2.5bn British Patient Capital Programme Launched to Enable Long-term Investment in Innovative Companies across the UK". 2018-06-13
Mologic Ltd.. (6/13/18). "Press Release: Mologic and Newcastle University Launch BReD Diagnostic for Blackgrass Resistance at Cereals". Bedfordshire & Newcastle. 2018-06-13
AstraZeneca plc. (6/12/18). "Press Release: Update on Phase III Clinical Trials of Lanabecestat for Alzheimer’s Disease. Independent Data Monitoring Committee Advises Lanabecestat Is Unlikely to Meet Primary Endpoints, Leading to Decision to Discontinue 2018-06-12
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Linda Bain to Its Board of Directors". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Launches Roadshow for Initial Public Offering". London. 2018-06-08
Kandy Therapeutics Ltd.. (6/7/18). "Press Release: KandyTherapeutics Announces Positive Clinical Data with Lead Candidate NT-814 for the Treatment of Symptoms of the Menopause". Stevenage. 2018-06-07
Microbiotica Ltd.. (6/6/18). "Press Release: Microbiotica Enters into Microbiome Collaboration with Genentech". Cambridge. 2018-06-06
Oxford BioMedica plc. (6/6/18). "Press Release: Oxford BioMedica and Axovant Sciences Enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease". Oxford. 2018-06-06
University of Oxford. (6/6/18). "Press Release: Rosalind Franklin Institute Will »Transform« Life Sciences Research through Disruptive Technologies". 2018-06-06
Sygnature Discovery Ltd.. (6/1/18). "Press Release: Sygnature Discovery Focuses on US Expansion with the Appointment of Dr Bill Marathias". Nottingham. 2018-06-01
F-Star Biotechnology Ltd.. (5/30/18). "Press Release: F-Star Announces Early Exercise by Denali Therapeutics of Its Option to Acquire F-star Gamma". Cambridge. 2018-05-30
Waters Corporation. (5/29/18). "Press Release: Waters DART QDa System with LiveID Software Instantly Assesses Food Quality and Authenticity". Milford, MA. 2018-05-29
Bicycle Therapeutics Ltd.. (5/25/18). "Press Release: Bicycle Therapeutics Announces Clinical Milestone and Expands Collaboration with Thrombogenics". Cambridge & Boston, MA. 2018-05-25
Microsaic Systems plc. (5/24/18). "Press Release: Distribution Agreement with Stable Arm Sdn. Bhd.". 2018-05-24
Bicycle Therapeutics Ltd.. (5/24/18). "Press Release: Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca". Cambridge & Boston, MA. 2018-05-24
Orbit Discovery Ltd.. (5/23/18). "Press Release: Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing". Oxford. 2018-05-23
HalioDx S.A.S.. (5/22/18). "Press Release: HalioDx Signs an Agreement with Everything Genetic to Make Immunoscore Colon Assay Available in the United Kingdom". Marseille. 2018-05-22
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. 2018-05-21
F-Star Biotechnology Ltd.. (5/21/18). "Press Release: F-Star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody". Cambridge. 2018-05-21
Thermo Fisher Scientific Inc.. (5/16/18). "Press Release: Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development". Hillsboro, OR. 2018-05-16
Bionure. (5/16/18). "Press Release: Bionure Initiates a Phase 1 Clinical Trial of Its Lead Compound BN201 in the United Kingdom". Barcelona. 2018-05-16
Premaitha Health plc. (5/15/18). "Press Release: Year-end Trading Update and £2.5m Fundraising". Manchester. 2018-05-15
PhoreMost Ltd.. (5/15/18). "Press Release: PhoreMost Completes $15M (£11M) Series A Round to Enter Drug Discovery". Cambridge. 2018-05-15
CellCentric Ltd.. (5/15/18). "Press Release: CellCentric Raises $26 Million to Take First-in-Class p300/CBP Inhibitor into the Clinic". 2018-05-15
Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. 2018-05-15
IP Group plc. (5/15/18). "Press Release: IP Group and Johns Hopkins Collaboration Funds Cancer Therapeutic Start-up". 2018-05-15
Brainomix Ltd.. (5/11/18). "Press Release: Brainomix Announces CE Mark Certification for New e-CTA Software". Oxford. 2018-05-11
AstraZeneca plc. (5/11/18). "Press Release: AstraZeneca Provides Update on GALATHEA Phase III Trial for Fasenra in Chronic Obstructive Pulmonary Disease". 2018-05-11
Oxford Nanopore Technologies Ltd.. (5/9/18). "Press Release: Oxford Nanopore Announces Favourable Outcome in UK and German Patent Litigation against Pacific Biosciences". 2018-05-09
Microsaic Systems plc. (5/9/18). "Press Release: Microsaic Signs Agreement with Rightek Co., Ltd.". 2018-05-09
Horizon Discovery Group plc. (5/8/18). "Press Release: Horizon Discovery Appoints Terry Pizzie as Chief Executive Officer". Cambridge. 2018-05-08
Scancell Holdings plc. (5/8/18). "Press Release: Result of Open Offer and PDMR Shareholdings". 2018-05-08
TC BioPharm Ltd.. (5/8/18). "Press Release: TC BioPharm Broadens CAR-T Drug Pipeline". Glasgow & Aberdeen. 2018-05-08
Autolus Therapeutics Ltd.. (5/8/18). "Press Release: Autolus Files for Proposed Initial Public Offering in the United States". London. 2018-05-08
AstraZeneca plc. (5/8/18). "Press Release: Lynparza Tablets Receive EU Approval for the Treatment of Platinum-sensitive Relapsed Ovarian Cancer". 2018-05-08
AstraZeneca plc. (5/7/18). "Press Release: AstraZeneca and Luye Pharma Group Enter Agreement for Rights to Seroquel and Seroquel XR in the UK, China and Other International Markets". 2018-05-07
Orchard Therapeutics Ltd.. (5/3/18). "Press Release: Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy". Boston, MA & London. 2018-05-03
Mercia Technologies plc. (5/2/18). "Press Release: Mercia’s First University of Edinburgh Investment Offers Dialysis Hope". 2018-05-02
Eagle Genomics Ltd.. (5/1/18). "Press Release: Eagle Genomics Announces Senior Leadership Changes". Cambridge. 2018-05-01
Oxford Immunotec Global plc. (5/1/18). "Press Release: Oxford Immunotec Reports First Quarter 2018 Financial Results". Oxford & Marlborough, MA. 2018-05-01
Mologic Ltd.. (5/1/18). "Press Release: Mologic Signs Agreements with Medisur and Peripal to Distribute Periplex PoC Diagnostic in Europe". Bedfordshire. 2018-05-01
PredictImmune Ltd.. (4/30/18). "Press Release: PredictImmune Secures £4.3m Investment from Wellcome Trust to Evaluate The Clinical Utility of Its Prognostic Test in Crohn’s Disease". Cambridge. 2018-04-30
Crescendo Biologics Ltd.. (4/30/18). "Press Release: Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing". Cambridge. 2018-04-30
Jellagen Pty. Ltd.. (4/27/18). "Press Release: Marine Biotechnologies Firm Jellagen on Course for Accelerated Growth Thanks to £3.8m Funding from Newable Private Investing, Development Bank of Wales and Angel Investors". Cardiff. 2018-04-27
Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. 2018-04-26
PureTech Health plc. (4/24/18). "Press Release: PureTech Health Appoints Joep Muijrers as Chief Financial Officer". 2018-04-24
AstraZeneca plc. (4/24/18). "Press Release: AstraZeneca Reports Results from the ARCTIC Trial in Third-line Non-small Cell Lung Cancer". 2018-04-24
Orchard Therapeutics Ltd.. (4/24/18). "Press Release: Orchard Therapeutics Expands US Presence with New Corporate Office in Boston". Boston, MA & London. 2018-04-24
Redx Pharma plc. (4/24/18). "Press Release: Redx Appoints Senior AstraZeneca Executive as CEO". Alderley Park. 2018-04-24
BenevolentAI. (4/19/18). "Press Release: BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development". 2018-04-19
GlaxoSmithKline plc. (4/18/18). "Press Release: GSK Appoints Kevin Sin as New SVP and Head of Worldwide Business Development for R&D". London. 2018-04-18
Adaptimmune Therapeutics plc. (4/16/18). "Press Release: Adaptimmune Presents MAGE-A4 and MAGE-A10 Pre-clinical Data at American Association for Cancer Research (AACR) Annual Meeting". Philadeliphia, PA & Oxford. 2018-04-16
Crescendo Biologics Ltd.. (4/16/18). "Press Release: Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda". Cambridge. 2018-04-16
Enterprise Therapeutics Ltd.. (4/12/18). "Press Release: Enterprise Therapeutics Raises £29 Million ($41 Million USD) Funding". Brighton. 2018-04-12
BioAscent Discovery Ltd.. (4/12/18). "Press Release: BioAscent Establishes Integrated Drug Discovery Services Offering". Newhouse. 2018-04-12
Microsaic Systems plc. (4/12/18). "Press Release: Microsaic Signs Agreement with Knauer". 2018-04-12
Adaptimmune Therapeutics plc. (4/12/18). "Press Release: Adaptimmune Announces Changes to Board of Directors". Philadeliphia, PA & Oxford. 2018-04-12
GlaxoSmithKline plc. (4/12/18). "Press Release: GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics". London. 2018-04-12
Microsaic Systems plc. (4/10/18). "Press Release: Microsaic Systems Launches 4500 MiD for Point-of-need Mass Spectrometry at Analytica 2018". 2018-04-10
Consilium Strategic Communications Ltd.. (4/9/18). "Press Release: Consilium Strategic Communications Appoints GSK’s David Daley as Senior Associate Partner". London. 2018-04-09
Markes International Ltd.. (4/9/18). "Press Release: New Sample Preparation and Concentration Platform Marks a Major Advance in Automation of GC–MS Workflows". Llantrisant. 2018-04-09
Iontas Ltd.. (4/4/18). "Press Release: Iontas and Igem Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets". Cambridge. 2018-04-04
Brainomix Ltd.. (4/3/18). "Press Release: Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes with AI". Oxford. 2018-04-03
Peak Scientific Instruments Ltd.. (4/2/18). "Press Release: Peak Scientific Introduces New Solaris XE Nitrogen Generator". 2018-04-02
Redx Pharma plc. (3/29/18). "Press Release: RXC004 Clinical Trial Update". Alderley Park. 2018-03-29
Microsaic Systems plc. (3/28/18). "Press Release: Agreement with Unimicro Technologies Inc". 2018-03-28
Life Sciences Hub Wales. (3/27/18). "Press Release: £200m Life Sciences Village Planned For Llanelli". 2018-03-27
GlaxoSmithKline plc. (3/27/18). "Press Release: GSK Reaches Agreement with Novartis to Acquire Full Ownership of Consumer Healthcare Business". 2018-03-27
Microsaic Systems plc. (3/23/18). "Press Release: Microsaic Signs Commercial Contract with CPI Innovation Services Ltd". 2018-03-23
Redx Pharma plc. (3/22/18). "Press Release: Redx Pharma Signs Option and Licence Agreement for Its Anti-infective Programme with Deinove". Alderley Park & Grabels. 2018-03-22
Deinove S.A.. (3/22/18). "Press Release: Deinove Expands Its Innovative Antibiotic Portfolio by Signing a License and Option Agreement with Redx Pharma". Montpellier. 2018-03-22
Orchard Therapeutics Ltd.. (3/21/18). "Press Release: Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel". London. 2018-03-21
Oxford Nanopore Technologies Ltd.. (3/20/18). "Press Release: Oxford Nanopore Announces £100 Million ($140M) Fundraising from Global Investors". Oxford. 2018-03-20
BRAIN AG. (3/17/18). "Press Release: BRAIN AG Acquires Majority Stake of Leading Speciality Enzyme Producer Biocatalysts Ltd.". Zwingenberg & Cardiff. 2018-03-17
Arix Bioscience plc. (3/16/18). "Press Release: Results of Capital Raising [Not for United States, Australia, Canada, Japan, New Zealand, The Republic of Ireland or the Republic of South Africa or other Jursidcitions Where Unlawful]". 2018-03-16
Microsaic Systems plc. (3/15/18). "Press Release: Final Results for the Year Ended 31 December 2017". 2018-03-15
Dotmatics Ltd.. (3/15/18). "Press Release: Dotmatics Appoints Gordon McCall as Chief Financial Officer". Bishop’s Stortford. 2018-03-15
Coulter Partners. (3/14/18). "Press Release: Coulter Partners Secures CEO for George Health Technologies". 2018-03-14
OxSyBio Ltd.. (3/12/18). "Press Release: OxSyBio Ltd Secures £10m Series A Led by Woodford". 2018-03-12
Domainex Ltd.. (3/12/18). "Press Release: Domainex Appoints Dr Bodo Spori as Head of Business Development for Europe". Cambridge. 2018-03-12
Selcia Ltd.. (3/8/18). "Press Release: Parkinson’s UK, Selcia, and Cresset Collaborate to Discover New Drug Candidates for Parkinson's". London, Ongar & Cambridge. 2018-03-08
Oxford Vacmedix UK Ltd.. (3/6/18). "Press Release: Cancer Vaccine Firm Oxford Vacmedix Closes $12.5m Series A Funding". Oxford. 2018-03-06
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26  next pagenext page



Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px

» top